Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.
Felipe SantelicesDaniela MasoliJavier KattanAlberto TosoMatías LucoPublished in: Journal of perinatology : official journal of the California Perinatal Association (2024)
This study showed that the use of vasopressin in neonates with persistent pulmonary hypertension was associated with a rapid and significant improvement in oxygenation and hemodynamic markers of perfusion, including blood pressure. Its effects begin early during the first hours of treatment.
Keyphrases
- pulmonary hypertension
- blood pressure
- pulmonary artery
- pulmonary arterial hypertension
- low birth weight
- gestational age
- preterm infants
- pregnant women
- stem cells
- heart rate
- magnetic resonance imaging
- type diabetes
- adipose tissue
- computed tomography
- metabolic syndrome
- mesenchymal stem cells
- insulin resistance
- blood glucose
- smoking cessation